Are you Dr. Barlin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 67 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
319 S Manning Blvd
Ste 301
Albany, NY 12208Phone+1 518-458-1390Fax+1 518-459-3271
Summary
- Dr. Joyce Barlin, MD is an obstetrician/gynecologist in Albany, New York. She is currently licensed to practice medicine in New York. She is affiliated with St. Peter's Hospital, Albany Medical Center, and Vassar Brothers Medical Center.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Gynecologic Oncology, 2011 - 2014
Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 2006 - 2010
Albany Medical CollegeClass of 2006
Certifications & Licensure
NY State Medical License 2010 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 134 citationsA Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov...Bradley J Monk, Christine Parkinson, Myong Cheol Lim, David M O'Malley, Ana Oaknin
Journal of Clinical Oncology. 2022-12-01 - 117 citationsCytoreductive surgery for advanced or recurrent endometrial cancer: A meta-analysisJoyce N. Barlin, Isha Puri, Robert E. Bristow
Gynecologic Oncology. 2010-07-01 - 42 citationsValidated gene targets associated with curatively treated advanced serous ovarian carcinomaJoyce N. Barlin, Petar Jelinic, Narciso Olvera, Faina Bogomolniy, Maria Bisogna
Gynecologic Oncology. 2012-03-01
Press Mentions
UPDATE - OncoC4 Announces First Patient Dosed in PRESERVE-004, a Phase 2 Clinical Trial of ONC-392 in Combination with KEYTRUDA® (Pembrolizumab) in Patients with Platinum-Resistant Ovarian CancerDecember 30th, 2022
